Sector ratings Daiichi Sankyo Company, Limited

Equities

Delayed Japan Exchange Other stock markets 12:00:00 13/04/2026 pm IST			5-day change	1st Jan Change
2,731.50 ^JPY	-1.48%		-4.43%	-18.41%

08/04	Atlatl Innovation Center And Daiichi Sankyo Enter Agreement To Deepen Apac Biotech Innovation	CI
02/04	Astrazeneca plc Announces Positive High-Level Results from the Emerald-3 Phase III Trial	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation	Consensus
DAIICHI SANKYO COMPANY, LIMITED	3.2TCr	AAA
ELI LILLY AND COMPANY	84TCr	A
JOHNSON & JOHNSON	57TCr	BBB
ABBVIE INC.	37TCr	AA
ROCHE HOLDING AG	32TCr	AA	-	-
ASTRAZENECA PLC	32TCr	A
MERCK & CO., INC.	30TCr	A
NOVARTIS AG	29TCr	AAA
AMGEN INC.	19TCr	A
GILEAD SCIENCES, INC.	17TCr	AA
NOVO NORDISK A/S	17TCr	A
PFIZER INC.	15TCr	A
BRISTOL-MYERS SQUIBB COMPANY	12TCr	A
GSK PLC	12TCr	AA
SANOFI	11TCr	AA
VERTEX PHARMACEUTICALS INCORPORATED	11TCr	AA
CHUGAI PHARMACEUTICAL CO., LTD.	8.97TCr	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.69TCr	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	5.54TCr	AA
BAYER AG	4.63TCr	AA
Average	22.2TCr	AA
Weighted average by Cap.		AA